The Autism Center of Excellence at Duke University developed a tablet-based application called SenseToKnow to screen toddlers aged 17 months to three years for autism during well-child visits. The app recorded an 87.8% accuracy rate for detecting autism spectrum disorder (ASD) and an 80.8% specificity for children without ASD who screened negative in a study of 475 toddlers. This is a much higher likelihood of a correct diagnosis compared to traditional questionnaires, reducing disparities in early autism diagnoses.
FDA approves breast cancer drug
The FDA has approved Eli Lilly’s imlunestrant, an oral estrogen receptor antagonist, for the treatment of adults with estrogen receptor positive, HER2-negative, ESR1-mutated advanced or
